Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Enhancer box (E-box) DNA element is a conserved hexanucleotide sequence, typically following the CANNTG consensus motif, located within the promoter and enhancer regions of various genes. In the context of skeletal muscle, these sites are critical for the spatial and temporal regulation of muscle-specific gene expression (Massari & Murre, 2000, Mol Cell Biol). They serve as the primary docking sites for Myogenic Regulatory Factors (MRFs) such as MyoD, Myf5, myogenin, and MRF4, which are basic helix-loop-helix (bHLH) transcription factors that drive the differentiation of mesenchymal stem cells into mature myofibers (Tapscott, 2005, Genes & Dev). By recruiting co-activators like p300 and PCAF, the binding of MRFs to E-boxes facilitates chromatin remodeling and the assembly of the basal transcription machinery (Sartorelli & Caretti, 2005, Front Biosci). In modern pharmacology and regenerative medicine, E-box elements are strategically utilized in the design of synthetic, muscle-specific promoters for gene therapy. For instance, therapies for Duchenne muscular dystrophy often employ promoters containing multiple E-box motifs to ensure that therapeutic transgenes, such as micro-dystrophin, are expressed exclusively in cardiac and skeletal muscle tissues, thereby reducing systemic toxicity (Wang et al., 2008, Gene Ther). Dysregulation or mutations affecting E-box binding sites or their cognate transcription factors are linked to various pathologies, including rhabdomyosarcoma, where myogenic differentiation is arrested, and various forms of muscular dystrophy where the downstream contractile apparatus is compromised.
Recruitment of basic helix-loop-helix (bHLH) myogenic regulatory factors to the CANNTG consensus sequence to initiate muscle-specific transcription.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enhancer box DNA element (E-box).